Table 2.
Expression of VISTA and PD-L1 in TCs and tumor-infiltrating ICs in bladder cancer
| Total n (%) |
VISTA in ICs | VISTA in TCs | |||
|---|---|---|---|---|---|
| Positive n (%) |
Negative n (%) |
Positive n (%) |
Negative n (%) |
||
| 108 (67.9) | 51 (32.1) | 49 (30.8) | 110 (69.2) | ||
| PD-L1 in ICs | p < 0.0001 | p = 0.2034 | |||
| Positive | 66 (41.5) | 59 (89.4) | 7 (10.6) | 24 (36.4) | 42 (63.6) |
| Negative | 93 (58.5) | 49 (52.7) | 44 (47.3) | 25 (26.9) | 68 (73.1) |
| PD-L1 in TCs | p = 0.05 | p = 0.2128 | |||
| Positive | 13 (8.0) | 12 (92.3) | 1 (7.7) | 6 (46.2) | 7 (53.8) |
| Negative | 146 (91.8) | 96 (65.7) | 50 (34.2) | 43 (29.5) | 103 (70.5) |